KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Receivables (2016 - 2025)

Teladoc Health's Receivables history spans 12 years, with the latest figure at $201.7 million for Q4 2025.

  • For Q4 2025, Receivables fell 9.96% year-over-year to $201.7 million; the TTM value through Dec 2025 reached $201.7 million, down 9.96%, while the annual FY2025 figure was $201.7 million, 9.96% down from the prior year.
  • Receivables for Q4 2025 was $201.7 million at Teladoc Health, down from $219.5 million in the prior quarter.
  • Across five years, Receivables topped out at $243.2 million in Q1 2025 and bottomed at $178.1 million in Q3 2021.
  • The 5-year median for Receivables is $225.1 million (2022), against an average of $217.5 million.
  • The largest annual shift saw Receivables surged 152.25% in 2021 before it fell 9.96% in 2025.
  • A 5-year view of Receivables shows it stood at $190.1 million in 2021, then rose by 23.94% to $235.6 million in 2022, then dropped by 2.37% to $230.1 million in 2023, then dropped by 2.65% to $224.0 million in 2024, then dropped by 9.96% to $201.7 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Receivables are $201.7 million (Q4 2025), $219.5 million (Q3 2025), and $234.0 million (Q2 2025).